CEO Tried AI in Drug Testing–Here’s Why It Failed

In today’s episode, Dinkar Sindhu, CEO of Axis Clinicals, dives into the world of clinical research and the cautious integration of AI in drug development. From testing groundbreaking GLP-1 drugs like Ozempic to navigating the complexities of FDA approvals, Dinkar reveals the meticulous process...